Ferutinin stability in human plasma and interaction with human serum albumin. 2008

H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
Holy Spirit University of Kaslik, Faculty of Sciences and Computer Engineering, B.P. 446 Jounieh, Lebanon. helenegreige@usek.edu.lb

Ferutinin is a potent phytoestrogen extracted from plants of the genus Ferula. The biological activity of this sesquiterpene is associated with the esterification of p-hydroxybenzoic acid with the daucane alcohol, jaeschkeanadiol. A HPLC method was developed to investigate the stability of ferutinin in acidic and basic solutions (pH 1.5 and 9.0, respectively), in buffer (pH 7.4) as well as in serial dilutions of albumin and in human plasma. The degradation of ferutinin was relatively slow at physiological pH 7.4 compared with low or high pH. Ferutinin was fully stable in human plasma as well as in albumin solution and the stability increased with albumin concentration. The binding of ferutinin to albumin was investigated by fluorescence spectroscopy. Ferutinin decreased the fluorescence of HSA and that of the only tryptophan residue located in domain IIA. As a result of the interaction between ferutinin and albumin, the binding of bilirubin decreased. The stability of ferutinin in plasma is attributable to ferutinin-albumin binding.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003508 Cycloheptanes Seven-carbon cycloparaffin cycloheptane (the structural formula (CH2)7) and its derivatives.
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D001565 Benzoates Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure. Benzoate,Benzoic Acids,Acids, Benzoic
D001643 Bridged Bicyclo Compounds Saturated alicyclic hydrocarbon molecules consisting of two rings that have two non-adjacent atoms in common. Bicyclo Compounds,Bicyclo Compounds, Bridged
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
April 1971, Arzneimittel-Forschung,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
February 1971, Journal of pharmaceutical sciences,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
January 2004, Bioorganic & medicinal chemistry,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
October 1990, Biochemical pharmacology,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
December 2015, Toxins,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
July 1993, Die Pharmazie,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
March 2000, Biochimica et biophysica acta,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
January 1975, Biofizika,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
July 1981, Molecular pharmacology,
H Greige-Gerges, and Y Diab, and J Farah, and J Magdalou, and C Haddad, and N Ouaini
January 1975, Biochemical pharmacology,
Copied contents to your clipboard!